WuXi AppTec Co., Ltd. (2359.HK) HKSE

106.00

-1.8(-1.67%)

Updated at March 13 04:08PM

Currency In HKD

Key Executives

Name	Title	Pay	Year Born
Minzhang Chen	Co-CEO & Executive Director	18.44M	1969
Qing Yang	Co-CEO & Executive Director	18.44M	1969
Ge Li	Co-Founder, Executive Chairman, President & Chief Executive Officer	46.16M	1967
Zhaohui Zhang	Chief Operating Officer of China, Executive Vice President & Executive Director	8.9M	1969
Howard Wu	Senior Vice President, General Counsel, Global Head of HR & Deputy Director of WuXi AppTec Management Institute	0	N/A
Jingchao Dong	Senior VP & RCS Senior Advisor	0	N/A
Youchu Wang	Senior VP & Head of STA API Early Phase Development	0	N/A
Ruijia Tang	IR Director	0	N/A
Tao Guo	Senior VP and Head of RCS BD&IPM	0	N/A
Ming Shi	Senior VP & CFO	0	1974

Name

Title

Pay

Year Born

Minzhang Chen

Co-CEO & Executive Director

18.44M

1969

Qing Yang

Co-CEO & Executive Director

18.44M

1969

Ge Li

Co-Founder, Executive Chairman, President & Chief Executive Officer

46.16M

1967

Zhaohui Zhang

Chief Operating Officer of China, Executive Vice President & Executive Director

8.9M

1969

Howard Wu

Senior Vice President, General Counsel, Global Head of HR & Deputy Director of WuXi AppTec Management Institute

N/A

Jingchao Dong

Senior VP & RCS Senior Advisor

N/A

Youchu Wang

Senior VP & Head of STA API Early Phase Development

N/A

Ruijia Tang

IR Director

N/A

Tao Guo

Senior VP and Head of RCS BD&IPM

N/A

Ming Shi

Senior VP & CFO

1974

Description

WuXi AppTec Co., Ltd., an investment holding company, provides research, development, and manufacturing services to discover, develop, and manufacture small molecule drugs, and cell and gene therapies in the People's Republic of China, rest of Asia, the United States, Europe, and internationally. The company operates through six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides seamless drug and medical device testing services from preclinical testing to clinical trials; an integrated end-to-end solution to accelerate time to market for cell and gene therapies; drug discovery services to pharmaceutical and biotech customers; and clinical research services. WuXi AppTec Co., Ltd. was founded in 2000 and is headquartered in Shanghai, the People's Republic of China.